Ballentine Partners’s Steris STE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$383K Buy
1,822
+98
+6% +$21.8K ﹤0.01% 714
2026
Q2
$363K Sell
1,724
-562
-25% -$120K ﹤0.01% 697
2026
Q1
$506K Buy
2,286
+950
+71% +$232K 0.01% 528
2025
Q4
$339K Buy
1,336
+26
+2% +$6.53K ﹤0.01% 665
2025
Q3
$324K Buy
1,310
+28
+2% +$6.7K ﹤0.01% 682
2025
Q2
$308K Buy
1,282
+102
+9% +$23.7K ﹤0.01% 677
2025
Q1
$267K Buy
+1,180
New +$260K ﹤0.01% 668
2024
Q4
– Sell
-879
Closed -$213K – 942
2024
Q3
$213K Sell
879
-49
-5% -$11.5K ﹤0.01% 733
2024
Q2
$204K Buy
+928
New +$202K ﹤0.01% 691

Other funds holding STE

Ballentine Partners's STE Position: Q3 2026 in Review

Ballentine Partners increased its Steris (STE) stake by 5.7% in Q3 2026, buying an estimated $21.8K and bringing the position to 1,822 shares worth $383K. The position accounts for ﹤0.01% of the portfolio, ranked #714.

Ballentine Partners first reported a position in STE in Q2 2024 and has held it in 9 quarters since. The position peaked at $506K in Q1 2026. 683 funds tracked by Wall St. Rank hold STE as of Q3 2026.

  • Ballentine Partners held 1,822 shares of Steris worth $383K as of Q3 2026.
  • Ballentine Partners bought 98 Steris shares in Q3 2026, an estimated $21.8K.
  • Steris made up ﹤0.01% of Ballentine Partners's portfolio in Q3 2026, its #714 holding.
  • Ballentine Partners first reported a position in Steris in Q2 2024 and has held it in 9 quarters since.
  • Ballentine Partners's Steris position peaked at $506K in Q1 2026.
  • 683 funds tracked by Wall St. Rank held Steris as of Q3 2026.

Based on Ballentine Partners's 13F filing for Q3 2026, filed 13 Nov 2026.